Trial Profile
A longitudinal cohort study of denosumab for the treatment of vertebral fractures in patients with glucocorticoid-induced osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates; Prednisolone
- Indications Corticosteroid-induced osteoporosis; Vertebral fracture
- Focus Therapeutic Use
- 10 Feb 2016 New trial record